Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

mTORC2/Akt activation in adipocytes is required for adipose tissue inflammation in tuberculosis.

Martinez N, Cheng CY, Ketheesan N, Cullen A, Tang Y, Lum J, West K, Poidinger M, Guertin DA, Singhal A, Kornfeld H.

EBioMedicine. 2019 Jul;45:314-327. doi: 10.1016/j.ebiom.2019.06.052. Epub 2019 Jul 4.

2.

Group A streptococcal M-protein specific antibodies and T-cells drive the pathology observed in the rat autoimmune valvulitis model.

Sikder S, Price G, Alim MA, Gautam A, Scott Simpson R, Margaret Rush C, Lee Govan B, Ketheesan N.

Autoimmunity. 2019 Mar;52(2):78-87. doi: 10.1080/08916934.2019.1605356. Epub 2019 May 7.

PMID:
31062619
3.

BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells.

Sathkumara HD, Pai S, Aceves-Sánchez MJ, Ketheesan N, Flores-Valdez MA, Kupz A.

Front Immunol. 2019 Mar 21;10:532. doi: 10.3389/fimmu.2019.00532. eCollection 2019.

4.

Dysregulation of key cytokines may contribute to increased susceptibility of diabetic mice to Mycobacterium bovis BCG infection.

Alim MA, Sikder S, Sathkumara H, Kupz A, Rush CM, Govan BL, Ketheesan N.

Tuberculosis (Edinb). 2019 Mar;115:113-120. doi: 10.1016/j.tube.2019.02.005. Epub 2019 Feb 18.

PMID:
30948165
5.

Exposure to Solar UVR Suppresses Cell-Mediated Immunization Responses in Humans: The Australian Ultraviolet Radiation and Immunity Study.

Swaminathan A, Harrison SL, Ketheesan N, van den Boogaard CHA, Dear K, Allen M, Hart PH, Cook M, Lucas RM.

J Invest Dermatol. 2019 Jul;139(7):1545-1553.e6. doi: 10.1016/j.jid.2018.12.025. Epub 2019 Jan 23.

6.

Reply to Dale and Shulman.

Sikder S, Rush CM, Govan BL, Norton RE, Cunningham MW, McMillan DJ, Sriprakash KS, Ketheesan N.

J Infect Dis. 2019 Jan 29;219(4):675-676. doi: 10.1093/infdis/jiy561. No abstract available.

PMID:
30247617
7.

Comparison of a rapid immuno-chromatography assay with a standard ELISA for the detection of IgM and IgG antibodies against dengue viruses.

Murugananthan K, Coonghe PAD, Ketheesan N, Noordeen F.

Virusdisease. 2018 Jun;29(2):199-202. doi: 10.1007/s13337-018-0440-x. Epub 2018 Apr 17.

8.

Correction to: Flavonoid quercetin-methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis.

Haleagrahara N, Hodgson K, Miranda-Hernandez S, Hughes S, Kulur AB, Ketheesan N.

Inflammopharmacology. 2019 Feb;27(1):201. doi: 10.1007/s10787-018-0480-2.

PMID:
29663101
9.

Significance of Anti-Myosin Antibody Formation in Patients With Myocardial Infarction: A Prospective Observational Study.

O'Donohoe TJ, Schrale RG, Sikder S, Surve N, Rudd D, Ketheesan N.

Heart Lung Circ. 2019 Apr;28(4):583-590. doi: 10.1016/j.hlc.2018.03.008. Epub 2018 Mar 21.

PMID:
29653839
10.

Flavonoid quercetin-methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis.

Haleagrahara N, Hodgson K, Miranda-Hernandez S, Hughes S, Kulur AB, Ketheesan N.

Inflammopharmacology. 2018 Oct;26(5):1219-1232. doi: 10.1007/s10787-018-0464-2. Epub 2018 Apr 3. Erratum in: Inflammopharmacology. 2018 Apr 17;:.

PMID:
29616452
11.

Blood group AB is associated with severe forms of dengue virus infection.

Murugananthan K, Subramaniyam S, Kumanan T, Owens L, Ketheesan N, Noordeen F.

Virusdisease. 2018 Mar;29(1):103-105. doi: 10.1007/s13337-018-0426-8. Epub 2018 Feb 9.

12.

Group G Streptococcus Induces an Autoimmune Carditis Mediated by Interleukin 17A and Interferon γ in the Lewis Rat Model of Rheumatic Heart Disease.

Sikder S, Williams NL, Sorenson AE, Alim MA, Vidgen ME, Moreland NJ, Rush CM, Simpson RS, Govan BL, Norton RE, Cunningham MW, McMillan DJ, Sriprakash KS, Ketheesan N.

J Infect Dis. 2018 Jun 20;218(2):324-335. doi: 10.1093/infdis/jix637.

PMID:
29236994
13.

Redox-sensitive transcription factors play a significant role in the development of rheumatoid arthritis.

Le Rossignol S, Ketheesan N, Haleagrahara N.

Int Rev Immunol. 2018 May 4;37(3):129-143. doi: 10.1080/08830185.2017.1363198. Epub 2017 Sep 12. Review.

PMID:
28898138
14.

Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, Australia.

Morris JL, Fane A, Sarovich DS, Price EP, Rush CM, Govan BL, Parker E, Mayo M, Currie BJ, Ketheesan N.

Emerg Infect Dis. 2017 May;23(5). doi: 10.3201/eid2305.151417.

15.

Therapeutic effect of quercetin in collagen-induced arthritis.

Haleagrahara N, Miranda-Hernandez S, Alim MA, Hayes L, Bird G, Ketheesan N.

Biomed Pharmacother. 2017 Jun;90:38-46. doi: 10.1016/j.biopha.2017.03.026. Epub 2017 Mar 22.

PMID:
28342364
16.

A Cost-Effective Approach to Producing Animated Infographics for Immunology Teaching.

Bellei M, Welch P, Pryor S, Ketheesan N.

J Microbiol Biol Educ. 2016 Dec 2;17(3):477-479. doi: 10.1128/jmbe.v17i3.1146. eCollection 2016 Dec. No abstract available.

17.

Anti-mycobacterial function of macrophages is impaired in a diet induced model of type 2 diabetes.

Alim MA, Sikder S, Bridson TL, Rush CM, Govan BL, Ketheesan N.

Tuberculosis (Edinb). 2017 Jan;102:47-54. doi: 10.1016/j.tube.2016.12.002. Epub 2016 Dec 8.

PMID:
28061952
18.

The therapeutic potential of plant flavonoids on rheumatoid arthritis.

Hughes SD, Ketheesan N, Haleagrahara N.

Crit Rev Food Sci Nutr. 2017 Nov 22;57(17):3601-3613. doi: 10.1080/10408398.2016.1246413. Review.

PMID:
27874281
19.

Anti-troponin antibodies following myocardial infarction.

O'Donohoe TJ, Ketheesan N, Schrale RG.

J Cardiol. 2017 Jan;69(1):38-45. doi: 10.1016/j.jjcc.2016.07.018. Epub 2016 Sep 15. Review.

20.

Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages From Diabetic Mice.

Martinez N, Ketheesan N, West K, Vallerskog T, Kornfeld H.

J Infect Dis. 2016 Dec 1;214(11):1629-1637. Epub 2016 Sep 13.

21.

Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease.

Gorton D, Sikder S, Williams NL, Chilton L, Rush CM, Govan BL, Cunningham MW, Ketheesan N.

Autoimmunity. 2016 Dec;49(8):563-570. Epub 2016 Aug 25.

22.

Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate.

Batzloff MR, Fane A, Gorton D, Pandey M, Rivera-Hernandez T, Calcutt A, Yeung G, Hartas J, Johnson L, Rush CM, McCarthy J, Ketheesan N, Good MF.

Hum Vaccin Immunother. 2016 Dec;12(12):3089-3096. doi: 10.1080/21645515.2016.1222999. Epub 2016 Aug 19.

23.

Development of a diet-induced murine model of diabetes featuring cardinal metabolic and pathophysiological abnormalities of type 2 diabetes.

Morris JL, Bridson TL, Alim MA, Rush CM, Rudd DM, Govan BL, Ketheesan N.

Biol Open. 2016 Aug 15;5(8):1149-62. doi: 10.1242/bio.016790.

24.

Overrepresentation of Diabetes in Soft Tissue Nontuberculous Mycobacterial Infections.

Bridson T, Govan B, Ketheesan N, Norton R.

Am J Trop Med Hyg. 2016 Sep 7;95(3):528-30. doi: 10.4269/ajtmh.16-0104. Epub 2016 Jul 5.

25.

Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate.

McNeilly C, Cosh S, Vu T, Nichols J, Henningham A, Hofmann A, Fane A, Smeesters PR, Rush CM, Hafner LM, Ketheesan N, Sriprakash KS, McMillan DJ.

PLoS One. 2016 Jun 16;11(6):e0156639. doi: 10.1371/journal.pone.0156639. eCollection 2016.

26.

Defects in early cell recruitment contribute to the increased susceptibility to respiratory Klebsiella pneumoniae infection in diabetic mice.

Martinez N, Ketheesan N, Martens GW, West K, Lien E, Kornfeld H.

Microbes Infect. 2016 Oct;18(10):649-655. doi: 10.1016/j.micinf.2016.05.007. Epub 2016 May 30.

PMID:
27256462
27.

Correction for Johnson et al., Complete Genome Sequences for 59 Burkholderia Isolates, Both Pathogenic and Near Neighbor.

Johnson SL, Bishop-Lilly KA, Ladner JT, Daligault HE, Davenport KW, Jaissle J, Frey KG, Koroleva GI, Bruce DC, Coyne SR, Broomall SM, Ketheesan N, Mayo M, Hoffmaster A, Elrod MG, Wuthiekanun V, Tuanyok A, Norton R, Currie BJ, Wagner DM, Keim P, Li PE, Teshima H, Gibbons HS, Palacios GF, Rosenzweig CN, Redden CL, Xu Y, Minogue TD, Chain PS.

Genome Announc. 2016 Apr 21;4(2). pii: e00313-16. doi: 10.1128/genomeA.00313-16. No abstract available.

28.

The role of anti-myosin antibodies in perpetuating cardiac damage following myocardial infarction.

O'Donohoe TJ, Schrale RG, Ketheesan N.

Int J Cardiol. 2016 Apr 15;209:226-33. doi: 10.1016/j.ijcard.2016.02.035. Epub 2016 Feb 3. Review.

PMID:
26897075
29.

Diabetes: A Contributor to Tuberculosis in Tropical Australia.

Bridson T, Matthiesson A, Owens L, Govan B, Norton R, Ketheesan N.

Am J Trop Med Hyg. 2015 Sep;93(3):547-8. doi: 10.4269/ajtmh.15-0264. Epub 2015 Jun 8.

30.

Rapid diagnostics for melioidosis: a comparative study of a novel lateral flow antigen detection assay.

Robertson G, Sorenson A, Govan B, Ketheesan N, Houghton R, Chen H, AuCoin D, Dillon M, Norton R.

J Med Microbiol. 2015 Aug;64(8):845-8. doi: 10.1099/jmm.0.000098. Epub 2015 Jun 7.

31.

Polymer encapsulation of magnesium to control biodegradability and biocompatibility.

Bazaka K, Ketheesan N, Jacob MV.

J Nanosci Nanotechnol. 2014 Oct;14(10):8087-93.

PMID:
25942929
32.

Plasmacytoid dendritic cell bactericidal activity against Burkholderia pseudomallei.

Williams NL, Morris JL, Rush CM, Ketheesan N.

Microbes Infect. 2015 Apr;17(4):311-6. doi: 10.1016/j.micinf.2014.12.007. Epub 2014 Dec 19.

PMID:
25532693
33.

Neurotropic threat characterization of Burkholderia pseudomallei strains.

Morris J, Fane A, Rush C, Govan B, Mayo M, Currie BJ, Ketheesan N.

Emerg Infect Dis. 2015 Jan;21(1):58-63. doi: 10.3201/eid2101.131570.

34.

Investigations of wear particles and selected cytokines in human osteoarthritic knee joints.

Wang M, Ketheesan N, Peng Z.

Proc Inst Mech Eng H. 2014 Nov;228(11):1176-82. doi: 10.1177/0954411914559570.

PMID:
25500862
35.

Animal models to investigate the pathogenesis of rheumatic heart disease.

Rush CM, Govan BL, Sikder S, Williams NL, Ketheesan N.

Front Pediatr. 2014 Nov 4;2:116. doi: 10.3389/fped.2014.00116. eCollection 2014. Review.

36.

Emerging scrub typhus infection in the northern region of Sri Lanka.

Pradeepan JA, Ketheesan N, Murugananthan K.

BMC Res Notes. 2014 Oct 14;7:719. doi: 10.1186/1756-0500-7-719.

37.

Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N.

Immunology. 2015 Feb;144(2):171-85. doi: 10.1111/imm.12394. Review.

38.

The double burden: a new-age pandemic meets an ancient infection.

Bridson TL, Govan BL, Norton RE, Schofield L, Ketheesan N.

Trans R Soc Trop Med Hyg. 2014 Nov;108(11):676-8. doi: 10.1093/trstmh/tru135. Epub 2014 Aug 25.

PMID:
25159218
39.

Migration of dendritic cells facilitates systemic dissemination of Burkholderia pseudomallei.

Williams NL, Morris JL, Rush CM, Ketheesan N.

Infect Immun. 2014 Oct;82(10):4233-40. doi: 10.1128/IAI.01880-14. Epub 2014 Jul 28.

40.

Improved diagnosis of melioidosis using a 2-dimensional immunoarray.

Sorenson AE, Williams NL, Morris JL, Ketheesan N, Norton RE, Schaeffer PM.

Diagn Microbiol Infect Dis. 2013 Nov;77(3):209-15. doi: 10.1016/j.diagmicrobio.2013.07.009. Epub 2013 Sep 14.

PMID:
24041552
41.

Dietary composition of carbohydrates contributes to the development of experimental type 2 diabetes.

Hodgson K, Govan B, Ketheesan N, Morris J.

Endocrine. 2013 Apr;43(2):447-51. doi: 10.1007/s12020-013-9874-5. Epub 2013 Jan 17.

PMID:
23325363
42.

Bacteraemias in tropical Australia: changing trends over a 10-year period.

Porter S, Ketheesan N, Norton R.

Diagn Microbiol Infect Dis. 2013 Mar;75(3):266-70. doi: 10.1016/j.diagmicrobio.2012.11.017. Epub 2012 Dec 29.

PMID:
23276769
43.

Impaired early cytokine responses at the site of infection in a murine model of type 2 diabetes and melioidosis comorbidity.

Hodgson KA, Govan BL, Walduck AK, Ketheesan N, Morris JL.

Infect Immun. 2013 Feb;81(2):470-7. doi: 10.1128/IAI.00930-12. Epub 2012 Dec 3.

44.

Detection of Coxiella burnetii DNA in wildlife and ticks in northern Queensland, Australia.

Cooper A, Stephens J, Ketheesan N, Govan B.

Vector Borne Zoonotic Dis. 2013 Jan;13(1):12-6. doi: 10.1089/vbz.2011.0853. Epub 2012 Nov 30.

PMID:
23199271
45.

ELISA and immuno-polymerase chain reaction assays for the sensitive detection of melioidosis.

Cooper A, Williams NL, Morris JL, Norton RE, Ketheesan N, Schaeffer PM.

Diagn Microbiol Infect Dis. 2013 Feb;75(2):135-8. doi: 10.1016/j.diagmicrobio.2012.10.011. Epub 2012 Nov 21.

PMID:
23177220
46.

Veterinary infection control in Australia: is there control?

Attard K, Burrows E, Kotiranta-Harris K, Hedlefs R, Ketheesan N, Govan B.

Aust Vet J. 2012 Nov;90(11):438-41. doi: 10.1111/j.1751-0813.2012.00971.x. Epub 2012 Jul 17. Review.

PMID:
23106324
47.

Examination of trafficking of phagocytosed colloid particles in neutrophils using synchrotron-based X-ray fluorescence microscopy (XFM).

Ramsay SC, Cassidy N, de Jonge MD, Howard DL, Paterson D, Ketheesan N.

J Biol Phys. 2011 Sep;37(4):493-506. doi: 10.1007/s10867-011-9233-9. Epub 2011 Aug 26.

48.

Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity.

Morris J, Williams N, Rush C, Govan B, Sangla K, Norton R, Ketheesan N.

Infect Immun. 2012 Jun;80(6):2089-99. doi: 10.1128/IAI.00212-12. Epub 2012 Apr 2.

49.

Problems with the use of a lateral flow assay in the serodiagnosis of brucellosis.

Eales K, Ketheesan N, Norton R.

Pathology. 2011 Dec;43(7):755-7. doi: 10.1097/PAT.0b013e32834c72c8. No abstract available.

PMID:
22124267
50.

Cardiac myosin epitopes for monitoring progression of rheumatic fever.

Gorton DE, Govan BL, Ketheesan N, Sive AA, Norton RE, Currie BJ, Towers RJ, Mascaro-Blanco AI, Cunningham MW.

Pediatr Infect Dis J. 2011 Nov;30(11):1015-6. doi: 10.1097/INF.0b013e31823058dd. No abstract available.

Supplemental Content

Loading ...
Support Center